Ad is loading...
GNPX
Price
$1.03
Change
-$0.05 (-4.63%)
Updated
Dec 6, 04:59 PM (EDT)
GRI
Price
$0.78
Change
+$0.13 (+20.00%)
Updated
Dec 6, 04:59 PM (EDT)
Ad is loading...

GNPX vs GRI

Header iconGNPX vs GRI Comparison
Open Charts GNPX vs GRIBanner chart's image
Genprex
Price$1.03
Change-$0.05 (-4.63%)
Volume$10.3K
CapitalizationN/A
GRI Bio
Price$0.78
Change+$0.13 (+20.00%)
Volume$5.45K
CapitalizationN/A
GNPX vs GRI Comparison Chart
Loading...
GNPX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
GRI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
GNPX vs. GRI commentary
Dec 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNPX is a StrongSell and GRI is a StrongBuy.

COMPARISON
Comparison
Dec 08, 2024
Stock price -- (GNPX: $1.04 vs. GRI: $0.79)
Brand notoriety: GNPX and GRI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNPX: 4% vs. GRI: 15%
Market capitalization -- GNPX: $9.19M vs. GRI: $5.8M
GNPX [@Biotechnology] is valued at $9.19M. GRI’s [@Biotechnology] market capitalization is $5.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $489.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.71B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNPX’s FA Score shows that 0 FA rating(s) are green whileGRI’s FA Score has 1 green FA rating(s).

  • GNPX’s FA Score: 0 green, 5 red.
  • GRI’s FA Score: 1 green, 4 red.
According to our system of comparison, GRI is a better buy in the long-term than GNPX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNPX’s TA Score shows that 2 TA indicator(s) are bullish while GRI’s TA Score has 5 bullish TA indicator(s).

  • GNPX’s TA Score: 2 bullish, 6 bearish.
  • GRI’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, GRI is a better buy in the short-term than GNPX.

Price Growth

GNPX (@Biotechnology) experienced а -4.59% price change this week, while GRI (@Biotechnology) price change was +15.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.01%. For the same industry, the average monthly price growth was -2.68%, and the average quarterly price growth was +10.76%.

Reported Earning Dates

GNPX is expected to report earnings on May 29, 2024.

GRI is expected to report earnings on May 10, 2023.

Industries' Descriptions

@Biotechnology (-1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNPX($9.19M) has a higher market cap than GRI($5.8M). GNPX YTD gains are higher at: -88.696 vs. GRI (-97.745). GRI has higher annual earnings (EBITDA): -7.87M vs. GNPX (-22.82M). GRI has more cash in the bank: 4.75M vs. GNPX (1.49M). GRI has less debt than GNPX: GRI (131K) vs GNPX (279K). GNPX (0) and GRI (0) have equivalent revenues.
GNPXGRIGNPX / GRI
Capitalization9.19M5.8M158%
EBITDA-22.82M-7.87M290%
Gain YTD-88.696-97.74591%
P/E RatioN/A0.01-
Revenue00-
Total Cash1.49M4.75M31%
Total Debt279K131K213%
FUNDAMENTALS RATINGS
GNPX vs GRI: Fundamental Ratings
GNPX
GRI
OUTLOOK RATING
1..100
462
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
1
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6165
P/E GROWTH RATING
1..100
10066
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GRI's Valuation (1) in the null industry is somewhat better than the same rating for GNPX (54) in the Pharmaceuticals Major industry. This means that GRI’s stock grew somewhat faster than GNPX’s over the last 12 months.

GRI's Profit vs Risk Rating (100) in the null industry is in the same range as GNPX (100) in the Pharmaceuticals Major industry. This means that GRI’s stock grew similarly to GNPX’s over the last 12 months.

GRI's SMR Rating (100) in the null industry is in the same range as GNPX (100) in the Pharmaceuticals Major industry. This means that GRI’s stock grew similarly to GNPX’s over the last 12 months.

GNPX's Price Growth Rating (61) in the Pharmaceuticals Major industry is in the same range as GRI (65) in the null industry. This means that GNPX’s stock grew similarly to GRI’s over the last 12 months.

GRI's P/E Growth Rating (66) in the null industry is somewhat better than the same rating for GNPX (100) in the Pharmaceuticals Major industry. This means that GRI’s stock grew somewhat faster than GNPX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GNPXGRI
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 5 days ago
88%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 7 days ago
87%
View a ticker or compare two or three
Ad is loading...
GNPX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
GRI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HSAI10.430.99
+10.49%
Hesai Group American Depositary Share each ADS represents one
THM0.460.01
+1.98%
International Tower Hill Mines Ltd
GBR1.150.01
+0.78%
New Concept Energy
FULT21.240.08
+0.38%
Fulton Financial Corp
UHS194.22-1.83
-0.93%
Universal Health Services

GNPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNPX has been loosely correlated with REVB. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GNPX jumps, then REVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNPX
1D Price
Change %
GNPX100%
-3.70%
REVB - GNPX
48%
Loosely correlated
-3.04%
GRI - GNPX
33%
Loosely correlated
+21.73%
HOWL - GNPX
33%
Poorly correlated
+1.69%
AXON - GNPX
30%
Poorly correlated
-0.30%
TYRA - GNPX
30%
Poorly correlated
+3.69%
More

GRI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GRI has been loosely correlated with IDYA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if GRI jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRI
1D Price
Change %
GRI100%
+21.73%
IDYA - GRI
54%
Loosely correlated
+5.38%
NLSP - GRI
38%
Loosely correlated
-3.11%
GOVX - GRI
37%
Loosely correlated
+15.07%
SNSE - GRI
33%
Loosely correlated
-3.05%
GNPX - GRI
33%
Loosely correlated
-3.70%
More